Century Therapeutics, Inc. IPSC
1.20 USD -0.13 (-9.47%)
As ofNov 20, 2026, 12:08 PM EST
1.18 Day range 1.22
0.49 52-week range 2.94
- YTD
- +20.10%
- 1 year
- +143.38%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 109.16M | 6.59M | 2.23M | 5.20M | 0 | |
| 109.16M | 6.59M | 2.23M | 5.20M | 0 | |
| -17.27M | -138.14M | -146.55M | -133.83M | -94.88M | |
| -9.58M | -126.57M | -136.67M | -130.93M | -95.82M | |
| -0.14 | -1.61 | -2.30 | -2.27 | -2.96 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 64.21M | 61.21M | 49.30M | 86.24M | 58.16M | |
| 223.70M | 353.22M | 360.69M | 486.54M | 437.38M | |
| 64.77M | 191.85M | 175.94M | 183.81M | 41.14M | |
| 40.24M | 48.96M | 46.66M | 48.94M | 24.50M | |
| 158.94M | 161.36M | 184.75M | 302.74M | 396.24M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -103.88M | -110.14M | -88.35M | 14.05M | -89.00M | |
| 107.50M | 47.48M | 61.13M | -13.13M | -298.34M | |
| 173.00K | 74.56M | -9.72M | 27.16M | 417.77M | |
| -848.00K | -154.00K | -13.74M | -30.60M | -44.97M | |
| 3.80M | 11.91M | -36.94M | 28.08M | 30.43M |
